Back to Search

PETER EMERY, MD

MD

Internal Medicine Physician

NPI: 1649239765IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

015345(ME)

CMS Specialties

PrimaryINTERNAL MEDICINE

Education

GEISEL SCHOOL OF MEDICINE AT DARTMOUTH

Class of 1997

Research & Publications (20)

Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.
PMID 19644849·Arthritis Rheum·2009
3-trial
Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis.
PMID 19369462·J Rheumatol·2009
3-trial
Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.
PMID 19286904·Ann Rheum Dis·2009
4-observational
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.
PMID 18635256·Lancet·2008
4-observational
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.
PMID 18625622·Ann Rheum Dis·2008
4-observational
Circadian rhythms: timing the sense of smell.
PMID 18606130·Curr Biol·2008
7-preclinical
Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis.
PMID 18094000·Rheumatology (Oxford)·2008
6-review
Glia got rhythm.
PMID 17678846·Neuron·2007
6-review
Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis.
PMID 17505829·Rheumatol Int·2007
6-review
Protein extraction from Drosophila heads.
PMID 17417024·Methods Mol Biol·2007
7-preclinical
RNase protection assay.
PMID 17417021·Methods Mol Biol·2007
8-other
RNA extraction from Drosophila heads.
PMID 17417017·Methods Mol Biol·2007
7-preclinical
Mutagenesis with Drosophila.
PMID 17417010·Methods Mol Biol·2007
7-preclinical
Inhibiting toll-like receptors in inflammatory disease.
PMID 16950340·Lancet·2006
8-other
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.
PMID 16649186·Arthritis Rheum·2006
3-trial
Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.
PMID 16568505·J Rheumatol·2006
4-observational
Treatment of rheumatoid arthritis.
PMID 16424492·BMJ·2006
6-review
Building a new culture of aging: revolutionizing long-term care.
PMID 16363400·J Christ Nurs·2006
6-review
Introduction.
PMID 16357748·J Clin Rheumatol·2005
8-other
Metabolic changes in malnutrition.
PMID 16304580·Eye (Lond)·2005
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
84 MARGINAL WAY, SUITE 700
PORTLAND, ME 04101

Location

Practice Location

84 MARGINAL WAY, PORTLAND, ME
(207) 774-5816

Quick Facts

NPI
1649239765
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
29
Publications
20

Are you this provider?

Claim Your Profile